ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Diagnosis & Disease Information
Many Thyroid Cancer Survivors Cite Inadequate Pretreatment Understanding
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
Lifestyle May Counter Genetic Risk for Thyroid Cancer
The highest risk of thyroid cancer was seen in patients with both high genetic risk and an unfavorable lifestyle.
Cabozantinib Improves PFS in Radioiodine-Refractory Differentiated Thyroid Cancer
Cabozantinib prolongs progression-free survival in patients with previously treated radioiodine-refractory differentiated thyroid cancer, a phase 3 trial suggests.
Proton FLASH Radiotherapy Deemed Feasible, Comparable to Conventional Dose Rate Radiotherapy
Proton FLASH radiotherapy is feasible, safe, and provides pain relief for cancer patients with bone metastases, according to a first-in-human trial.
CHEK2 Pathogenic Variants Associated With Breast and Other Cancers
A retrospective evaluation of lab results linked the likelihood of certain cancer types with the presence of specific pathogenic variants in CHEK2.
Active Surveillance Feasible for Low-Risk Thyroid Cancer
Active surveillance may be a viable management strategy for most diagnosed thyroid cancers, according to researchers.
Donafenib May Be Alternative for Progressive, Advanced RAIR-DTC
Donafenib demonstrated efficacy in patients with progressive, locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Thyroid Cancer Often Detected in Asymptomatic Patients
Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.
US Is Home to More Than 18 Million Cancer Survivors
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...